Pharma BD Deal Intelligence
Waters Corporation (NYSE: WAT) announced on 3 November 2026, alongside its third-quarter 2026 results, that it had acquired MOBILion Systems, Inc., the developer of SLIM high-resolution ion mobility separation technology, which separates molecules by size, shape and charge in milliseconds. Waters stated the acquisition complements its mass spectrometry portfolio and is expected to broaden the company's entry into the proteomics market, pairing SLIM separation with the speed and resolution of Waters' Xevo MRT mass spectrometer to increase proteome coverage, sensitivity and throughput for complex biological samples. Waters sizes the LC-MS proteomics opportunity at roughly $2 billion. VALUE NOT INGESTED: Waters did not disclose the purchase price or any other financial terms, and no figure is available from the Form 8-K or the press release, so deal_value_usd_mm is left NULL rather than estimated. The transaction is described in the past tense as completed. This is a life-science-tools transaction with no therapeutic asset, so therapeutic_areas, lead_molecules and indications are intentionally left NULL. NOTE: ingested at pending_review by bd-enrichment-2026-11-06.
← Browse all deals · How we score deals
More: 2026 deals